Abstract:Background Noninvasive methods have been used for the assessment of hepatic steatosis in patients with nonalcoholic fatty liver disease (NAFLD). The aim was to assess the efficacy and accuracy of both magnetic resonance imaging(MRI) and transient elastography(TE) for the evaluation of hepatic steatosis. Materials and Methods The PubMed, Cochrane Library, Embase, MEDLINE and Web of Science databases were searched to retrieve studies examining the accuracy of MRI-proton density fat fraction(PDFF) and TE-controlled attenuation parameter(CAP) for evaluating the grading of steatosis(S0-S3) diagnosed by liver biopsy in NAFLD. We compared the sensitivity, specificity, hierarchical summary receiver operating characteristic curves(HSROC) and clinical utility of these methods. Results Twenty-four articles with a total of 2979 patients with NAFLD were included. The steatosis distribution was 8.1%/35.1%/32.2%/24.6% for S0/S1/S2/S3. For the diagnostic accuracy of MRI-PDFF, the HSROCs were 0.97 for >= S1, 0.91 for >= S2 and 0.90 for >= S3. For the diagnostic accuracy of TE-based CAP, the HSROCs were 0.85 for >= S1, 0.83 for >= S2 and 0.79 for >= S3. Following a 'positive' measurement (over the threshold value) for >= S1, the corresponding post-test probabilities of PDFF and CAP for the presence of steatosis were 82% and 61%, respectively, when the pretest probability was 24%. If the values were below these thresholds ('negative' results), the post-test probabilities were 3% and 7%. Conclusion MRI-PDFF and TE-CAP both provide highly accurate noninvasive approaches for quantifying and staging hepatic steatosis in NAFLD. Compared with TE-CAP, MRI-PDFF is significantly more accurate for evaluating dichotomized grades of steatosis.

MR Imaging Evaluation of Hepatic Fibrosis:State-of-The-Art Review

Recent advances in molecular magnetic resonance imaging of liver fibrosis.

[Functional MR Study of Hepatic Fibrosis].

Research progress in MR imaging of liver fibrosis

CT and MR Imaging Evaluation of Diffuse Parenchymal Diseases of Liver

[Advances in Evaluations of Liver Fibrosis Using Imaging Findings].

Advance of MRI T1ρ in Evaluation of Liver Fibrosis

Research progress in CT and MR for quantitative diagnosis of liver fibrosis

A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease

State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives

The imaging study and progress of liver fibrosis should be emphasized

Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future

Conventional and Artificial Intelligence-Based Computed Tomography and Magnetic Resonance Imaging Quantitative Techniques for Non-Invasive Liver Fibrosis Staging

Noninvasive staging of liver fibrosis: review of current quantitative CT and MRI-based techniques

Techniques and applications of magnetic resonance elastography in chronic liver disease

[Application and prospects of magnetic resonance imaging techniques in the diagnosis and evaluation of hepatocellular carcinoma]

Narrative review of magnetic resonance imaging in quantifying liver iron load

Research Status of Ultrasound Functional Imaging in Assessment of Hepatic Fibrosis

Non-invasive in vivo Imaging Grading of Liver Fibrosis

Advances of Noninvasive Methods in Diagnosis of Hepatic Fibrosis

Advances in Medical Imaging Evaluation of Fatty Liver